CR20140559A - Metodo para producir antígenos de haemophilus influenzae de tipo b - Google Patents

Metodo para producir antígenos de haemophilus influenzae de tipo b

Info

Publication number
CR20140559A
CR20140559A CR20140559A CR20140559A CR20140559A CR 20140559 A CR20140559 A CR 20140559A CR 20140559 A CR20140559 A CR 20140559A CR 20140559 A CR20140559 A CR 20140559A CR 20140559 A CR20140559 A CR 20140559A
Authority
CR
Costa Rica
Prior art keywords
haemophilus influenzae
influenzae type
producing antigens
producing
antigens
Prior art date
Application number
CR20140559A
Other languages
English (en)
Spanish (es)
Inventor
Hir Jérome Le
Pascal Loubiere
Fabien Barbirato
Nicholas Lindley
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of CR20140559A publication Critical patent/CR20140559A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CR20140559A 2012-07-02 2014-12-04 Metodo para producir antígenos de haemophilus influenzae de tipo b CR20140559A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1256329A FR2992656B1 (fr) 2012-07-02 2012-07-02 Procede de production d'antigenes haemophilus influenzae type b
PCT/FR2013/051549 WO2014006318A1 (fr) 2012-07-02 2013-07-02 Procédé de production d'antigènes haemophilus influenzae type b

Publications (1)

Publication Number Publication Date
CR20140559A true CR20140559A (es) 2015-04-06

Family

ID=47666183

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140559A CR20140559A (es) 2012-07-02 2014-12-04 Metodo para producir antígenos de haemophilus influenzae de tipo b

Country Status (33)

Country Link
US (2) US9556464B2 (https=)
EP (1) EP2885397B1 (https=)
JP (1) JP6347778B2 (https=)
KR (1) KR102051482B1 (https=)
CN (1) CN104583390B (https=)
AU (1) AU2013285306B2 (https=)
BR (1) BR112014033082B1 (https=)
CA (1) CA2878053C (https=)
CR (1) CR20140559A (https=)
CY (1) CY1120465T1 (https=)
DK (1) DK2885397T3 (https=)
ES (1) ES2681993T3 (https=)
FR (1) FR2992656B1 (https=)
GE (1) GEP201706788B (https=)
HR (1) HRP20181206T1 (https=)
HU (1) HUE038865T2 (https=)
IL (1) IL236208A0 (https=)
LT (1) LT2885397T (https=)
MX (1) MX358953B (https=)
NZ (1) NZ702471A (https=)
PE (1) PE20150192A1 (https=)
PH (1) PH12014502730A1 (https=)
PL (1) PL2885397T3 (https=)
PT (1) PT2885397T (https=)
RS (1) RS57495B1 (https=)
RU (1) RU2644246C2 (https=)
SG (1) SG11201408194SA (https=)
SI (1) SI2885397T1 (https=)
SM (1) SMT201800389T1 (https=)
TR (1) TR201810678T4 (https=)
UA (1) UA115787C2 (https=)
WO (1) WO2014006318A1 (https=)
ZA (2) ZA201500028B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2624014C1 (ru) * 2016-04-08 2017-06-30 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства России (ФГУП СПбНИИВС ФМБА России) Штамм haemophilus influenzae spb тип в - высокоактивный продуцент капсульного полисахарида полирибозилрибитолфосфата
CN109922828A (zh) 2016-10-20 2019-06-21 Km生物医药股份公司 使用具有降低了的分子量的PRP的Hib结合疫苗的制造方法
WO2018193475A2 (en) * 2017-04-22 2018-10-25 Biological E Limited An improved method for high level production of crm
RU2704452C1 (ru) * 2019-04-22 2019-10-28 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения вакцины гемофильной тип b конъюгированной
CN109975559B (zh) * 2019-04-29 2023-07-11 厦门稀土材料研究所 一种时间分辨荧光定量检测25羟基维生素d的试剂盒及方法
CN111000994A (zh) * 2019-12-26 2020-04-14 北京科兴中维生物技术有限公司 一种液体疫苗组合物及其制备方法与应用
CN112212779B (zh) * 2020-09-04 2022-05-17 厦门大学 一种水凝胶柔性应变传感器的制备方法
WO2022114735A1 (ko) * 2020-11-25 2022-06-02 주식회사 엘지화학 헤모필루스 인플루엔자 타입 b의 prp 항원 정제 공정의 품질 평가 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03183416A (ja) * 1989-12-12 1991-08-09 Shozo Oyama 菌根菌を培養する方法、およびその子実体を取得する方法
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
RU2258737C2 (ru) * 2003-09-01 2005-08-20 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Питательная среда для культивирования бактерий haemophilus influenzae типа b
FR2914302A1 (fr) * 2007-03-30 2008-10-03 Sanofi Pasteur Sa Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese
FR2918671B1 (fr) * 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
PE20100366A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
TW201129698A (en) * 2009-12-10 2011-09-01 Jgc Corp New cell culture method

Also Published As

Publication number Publication date
PE20150192A1 (es) 2015-02-27
GEP201706788B (en) 2017-12-11
EP2885397B1 (fr) 2018-05-30
CY1120465T1 (el) 2019-07-10
SG11201408194SA (en) 2015-01-29
KR102051482B1 (ko) 2019-12-03
JP6347778B2 (ja) 2018-06-27
WO2014006318A1 (fr) 2014-01-09
RS57495B1 (sr) 2018-10-31
US20170211111A1 (en) 2017-07-27
PL2885397T3 (pl) 2018-10-31
PT2885397T (pt) 2018-07-27
KR20150036311A (ko) 2015-04-07
MX2014014607A (es) 2015-02-12
PH12014502730B1 (en) 2015-02-02
UA115787C2 (uk) 2017-12-26
TR201810678T4 (tr) 2018-08-27
CN104583390A (zh) 2015-04-29
MX358953B (es) 2018-09-10
EP2885397A1 (fr) 2015-06-24
SMT201800389T1 (it) 2018-09-13
LT2885397T (lt) 2018-08-27
BR112014033082A2 (pt) 2017-06-27
PH12014502730A1 (en) 2015-02-02
HK1208493A1 (en) 2016-03-04
ZA201500028B (en) 2016-10-26
NZ702471A (en) 2017-08-25
HUE038865T2 (hu) 2018-12-28
CN104583390B (zh) 2018-07-10
US20150167036A1 (en) 2015-06-18
DK2885397T3 (en) 2018-08-06
RU2644246C2 (ru) 2018-02-08
ZA201500014B (en) 2016-10-26
CA2878053A1 (fr) 2014-01-09
IL236208A0 (en) 2015-01-29
BR112014033082B1 (pt) 2022-02-15
AU2013285306A1 (en) 2015-01-15
HRP20181206T1 (hr) 2018-10-05
RU2015103140A (ru) 2016-08-27
JP2015522272A (ja) 2015-08-06
FR2992656A1 (fr) 2014-01-03
CA2878053C (fr) 2021-07-06
ES2681993T3 (es) 2018-09-17
US9556464B2 (en) 2017-01-31
AU2013285306B2 (en) 2018-10-04
SI2885397T1 (sl) 2018-09-28
FR2992656B1 (fr) 2016-10-07
US10144940B2 (en) 2018-12-04

Similar Documents

Publication Publication Date Title
CR20140559A (es) Metodo para producir antígenos de haemophilus influenzae de tipo b
NI201400061A (es) Anticuerpos anti - phf - tau y sus usos
MX2015016535A (es) Metodo de produccion para tagatosa.
EP2853590A4 (en) METHOD FOR PRODUCING ANTIGEN-SPECIFIC T CELLS
GB201103836D0 (en) Conjugation process
DK3164414T3 (da) Antistoffer for IL-15
SMT202000372T1 (it) Metodo di purificazione di coniugati a base di il-15/il-15ralfa
IN2014DN08777A (https=)
MX2016010838A (es) Vacunas de proproteina convertasa subtilisina/kexina tipo 9 (pcsk9).
EP3088491A4 (en) PETROLKOKS AND MANUFACTURING METHOD THEREFOR
MX376905B (es) Metodo para preparar bifenilaminas a partir de azobencenos mediante catalisis de rutenio.
BR112015027977A2 (pt) método para a produção de formulações de óleo, formulações de óleo, e uso das formulações de óleo
MX382659B (es) Proceso para la preparación de derivados de tiazol.
BR112016009764A2 (pt) método para produção biossintética de acil-coa utilizando acil-coas sintase.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
SI3180547T1 (sl) Postopek za izdelavo vztrajnika
EA201492288A1 (ru) Способ получения сложных олигомерных структур
EP2840305A4 (en) METHOD FOR PRODUCING A REFLECTOR
MX2016005146A (es) Metodo para producir halocetonas.
TH1401007908A (th) วิธีเพื่อผลิตแอนติเจน Haemophilus influenzae ไทป์ b
TH1401007039A (th) วิธีการสำหรับการผลิตสารเสริมอาหารโดยใช้สาหร่ายไมโคร
UA98886U (en) Brucella abortus 7-26 strain for preparing a brucella rs-antigen
IN2013MU01305A (https=)